Cargando…
N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling
BACKGROUND: Glioblastomas multiforme (GBM) is the most devastating primary intracranial malignancy lacking effective clinical treatments. Notch2 has been established to be a prognostic marker and probably involved in GBM malignant progression. N-acetylcysteine (NAC), a precursor of intracellular glu...
Autores principales: | Deng, Jie, Liu, An-Dong, Hou, Guo-Qing, Zhang, Xi, Ren, Kun, Chen, Xuan-Zuo, Li, Shawn S. C., Wu, Yao-Song, Cao, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319015/ https://www.ncbi.nlm.nih.gov/pubmed/30606241 http://dx.doi.org/10.1186/s13046-018-1016-8 |
Ejemplares similares
-
N-acetylcysteine negatively regulates Notch3 and its malignant signaling
por: Zhang, Xiong, et al.
Publicado: (2016) -
Compatibility and aerosol characteristics of beclomethasone mixed with N-acetylcysteine
por: Wu, Xiufeng, et al.
Publicado: (2023) -
N-acetylcysteine (NAC) decreases binge eating in a rodent model
por: Hurley, Matthew M., et al.
Publicado: (2016) -
Cell senescence-associated genes predict the malignant characteristics of glioblastoma
por: Tan, Chenyang, et al.
Publicado: (2022) -
N-acetylcysteine Decreases Fibrosis and Increases Force-Generating Capacity of mdx Diaphragm
por: Burns, David P., et al.
Publicado: (2019)